TIF Guidelines for the Management of Transfusion-Dependent β-Thalassemia.
作者信息
Musallam Khaled M, Cappellini Maria Domenica, Porter John B, Farmakis Dimitrios, Eleftheriou Androulla, Angastiniotis Michael, Taher Ali T
机构信息
Center for Research on Rare Blood Disorders (CR-RBD), Burjeel Medical City Abu Dhabi United Arab Emirates.
Department of Public Health & Epidemiology Khalifa University Abu Dhabi United Arab Emirates.
出版信息
Hemasphere. 2025 Mar 5;9(3):e70095. doi: 10.1002/hem3.70095. eCollection 2025 Mar.
Abstract
摘要
相似文献
1
TIF Guidelines for the Management of Transfusion-Dependent β-Thalassemia.输血依赖型β地中海贫血管理的TIF指南
Hemasphere. 2025 Mar 5;9(3):e70095. doi: 10.1002/hem3.70095. eCollection 2025 Mar.
2
Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia.与镰状细胞病和地中海贫血相关的输血服务知识及免疫血液学实践。
Transfus Med. 2019 Jun;29(3):185-192. doi: 10.1111/tme.12580. Epub 2019 Feb 10.
3
2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia.2021年地中海贫血国际联合会输血依赖型地中海贫血管理指南
Hemasphere. 2022 Jul 29;6(8):e732. doi: 10.1097/HS9.0000000000000732. eCollection 2022 Aug.
4
Blood transfusion: quality and safety issues in thalassemia, basic requirements and new trends.输血：地中海贫血中的质量与安全问题、基本要求及新趋势。
Hemoglobin. 2009;33 Suppl 1:S28-36. doi: 10.3109/03630260903346593.
5
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies.改善输血依赖型β-地中海贫血患者的结局和生活质量：最佳临床实践建议和新型治疗策略的应用。
Expert Rev Hematol. 2021 Oct;14(10):897-909. doi: 10.1080/17474086.2021.1977116. Epub 2021 Sep 15.
6
Non-Transfusion-Dependent Thalassemia: A Panoramic Review.非输血依赖型地中海贫血症：全景综述。
Medicina (Kaunas). 2022 Oct 21;58(10):1496. doi: 10.3390/medicina58101496.
7
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia.卢司帕安治疗β地中海贫血患者的长期安全性和红系反应
Ther Adv Hematol. 2022 Dec 5;13:20406207221134404. doi: 10.1177/20406207221134404. eCollection 2022.
8
Red cell alloimmunization in transfusion-dependent and transfusion-independent beta thalassemia: A review from the Eastern Mediterranean Region (EMRO).输血依赖型和非输血依赖型β地中海贫血中的红细胞同种免疫：东地中海区域（EMRO）的综述
Transfus Apher Sci. 2019 Dec;58(6):102678. doi: 10.1016/j.transci.2019.102678. Epub 2019 Nov 7.
9
[Health status and quality of life in β-thalassemia adults in Marseille, France].[法国马赛β地中海贫血成年患者的健康状况与生活质量]
Rev Med Interne. 2024 Apr;45(4):187-193. doi: 10.1016/j.revmed.2024.01.005. Epub 2024 Mar 21.
10
Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study.索特瑞塞特，一种新型转化生长因子 β 配体陷阱，可改善 β-地中海贫血的贫血：一项 II 期、开放标签、剂量发现研究。
Haematologica. 2019 Mar;104(3):477-484. doi: 10.3324/haematol.2018.198887. Epub 2018 Oct 18.
本文引用的文献
1
Overall and complication-free survival in a large cohort of patients with β-thalassemia major followed over 50 years.50 多年来对大量重型β地中海贫血患者的总体生存率和无并发症生存率的研究。
Am J Hematol. 2023 Mar;98(3):381-387. doi: 10.1002/ajh.26798. Epub 2023 Jan 1.
2
Changing patterns in the epidemiology of β-thalassemia.β地中海贫血流行病学模式的变化
Eur J Haematol. 2020 Dec;105(6):692-703. doi: 10.1111/ejh.13512. Epub 2020 Sep 21.
3
The changing epidemiology of the ageing thalassaemia populations: A position statement of the Thalassaemia International Federation.衰老地中海贫血人群的流行病学变化：地中海贫血国际联合会立场声明。
Eur J Haematol. 2020 Jul;105(1):16-23. doi: 10.1111/ejh.13410. Epub 2020 Apr 15.
4
Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience.衰老的β-地中海贫血输血依赖患者的管理 - 意大利的经验。
Blood Rev. 2019 Nov;38:100594. doi: 10.1016/j.blre.2019.100594. Epub 2019 Aug 7.
Zotero 插件